About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, June 9th, 2015

The QualityStocks
Daily Stock List


Lightwave Logic, Inc. (LWLG)

PennyStocks24, SmallCap Fortunes, StockGuru, FeedBlitz, OTC Picks, Standout Stocks, and HotOTC reported earlier on Lightwave Logic, Inc. (LWLG), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Lightwave Logic is a technology business centering on the development of Next Generation Photonic Devices and Non Linear Optical Polymer Materials Systems for applications in high-speed fiber-optic telecommunications and data communications. The OTCQB-listed Company produces prototype electro-optic demonstration devices and is moving toward commercialization of its high-activity, high-stability organic polymers for applications in electro-optical device markets. Lightwave Logic is based in Longmont, Colorado.
The Company has a number of U.S. and international patent applications. These cover the Company’s composition of matter and spacer systems. Patents have been issued covering its basic Heterocyclical Chromophore Architecture and the Tricyclic Spacer systems.

Lightwave Logic is employing organic nonlinear electro-optical and all-optical polymers (plastic) as the foundation for a series of proprietary (internal and licensed to external partners) advanced Integrated Optical Devices that have comprehensive application in telecommunications, data communications, and also optical computing for use in military and commercial markets.  
The Company has integrated its proprietary Perkinamine™ chromophore technology with other chromophores based in part on aspects of proprietary, in-licensed technologies. This has resulted in a strong and durable nonlinear organic electro-optical (EO) material that will be utilized in photonic device development. It is based on Lightwave Logic’s new multi-chromophore approach, which permits two or more chromophores to work together.

Lightwave Logic earlier announced that initial thermal aging testing on its organic polymers indicates decades of operational performance as the Company prepares to process a series of commercially viable bleached waveguide devices. These are the initial products in a planned photonic device program.

The Company is also initiating side-by-side comparative testing of its organic polymers versus duplicate silicon photonic devices. The expectation is that such testing will provide results of its organic polymers' ability to improve a broad spectrum of performance parameters on photonic devices.

At the end of March 2015, Lightwave Logic announced that it significantly advanced the commercial feasibility of its organic electro-optical photonic device program. The results at 110C exceed the published results of any known electro-optical polymer at that temperature. Notably, they exceed the harsh demands of the commercial operating datacom/telecom environment, which requires photonic devices to operate consistently at 85C.

Recently, Lightwave Logic announced that it achieved operating capability of its in-house Class 100 Clean Room in which it will complete the development of prototype photonic devices enabled by its advanced organic electro-optic polymer material systems.

Mr. Tom Zelibor, Lightwave Logic Chairman and CEO, stated, "We are extremely pleased to have our own in-house Class 100 clean room.  This is an important milestone in the progression of Lightwave from solely a materials development company to now also having prototype photonic device development capabilities.  This will greatly accelerate the implementation of our goal to revolutionize optical communications with photonic devices based on our proprietary organic electro-optic polymer materials systems.”

Lightwave Logic, Inc. (LWLG), closed Tuesday's trading session at $0.785, down 0.63%, on 12,600 volume with 7 trades. The average volume for the last 60 days is 70,833 and the stock's 52-week low/high is $0.73/$1.25.

Peak Pharmaceuticals, Inc. (PKPH)

SmallCapVoice and TopPennyStockMovers reported earlier on Peak Pharmaceuticals, Inc. (PKPH), and we choose to report on the Company today, here at the QualityStocks Daily Newsletter.

Peak Pharmaceuticals, Inc. involves in the research, development, sales, and marketing of safe, hemp-based, medicinal products and supplements. The Company specializes in pharmaceutical-grade, hemp-based nutraceutical and supplement products for the human and animal health markets. Its’ goal is to become a worldwide leader in the research, development, sales, and marketing of medicinal hemp and cannabinoid products. Peak Pharmaceuticals is headquartered in Boulder County, Colorado.

The Company’s aim is to implement strict biotechnological and pharmaceutical standards in its R&D, operations, and manufacturing, to achieve the gold standard for hemp-based, CBD-containing products. It acquired an exclusive worldwide license and rights to the products and technologies developed by Canna-Pet LLC in late 2014 in exchange for royalties. Canna-Pet is a leading innovator of non-prescription cannabinoid products for animals.

Canna-Pet™ products for pet health are safe and legal. They are also non-GMO Hemp, made in the United States, and veterinarian recommended. The Company offers Canna-Pet™ products as capsules in four dosages, and as Canna-Biscuits™ treats.

Peak Pharmaceuticals’ plan is to develop enhanced and proprietary hemp extraction technologies and cultivars, and build a portfolio of intellectual property (IP). It will accomplish this through strategic collaborations with universities, clinicians, as well as research institutions.

The Company is first concentrating on expanding its presence in the veterinary market. It is working to launch new products and target global veterinary health markets. Along with this activity, it aims to develop new, proprietary hemp cultivars and hemp products for the human health markets, taking advantage of formulation and manufacturing experience gained from the Canna-Pet™ products, and in-house experience with drug discovery and development.

Peak has acquired additional scientific equipment for its laboratory facilities at the BioScience Park Center located on the Anschutz Medical Campus at the University of Colorado, Denver. Continuing research activities aim to take advantage of its 2014 hemp crop into product prototypes for testing, production, and ultimately innovative first-to-market hemp-based supplement products. The Company’s plan is to develop anti-inflammatory products targeted at the human health market, and also additional products for the veterinary market.

Today, Peak Pharmaceuticals announced the development and plans for release and marketing of Canna-Pet® Advanced120, a new product targeting small to mid-sized animals. The new 120mg product (formulated with Canna-Pet® Advanced) targets delivery of the entire cannabinoid profile of hemp. This includes CBD and terpenes. The design of Canna-Pet® Advanced120 is for small to mid-sized pets.

Peak Pharmaceuticals, Inc. (PKPH), closed Tuesday's trading session at $0.16, down 7.22%, on 394,225 volume with 28 trades. The average volume for the last 60 days is 63,548 and the stock's 52-week low/high is $0.1001/$1.18.

PetroTerra Corp. (PTRA)

InvestorSoup, Penny Stock Finder, Beacon Equity Research, Stock Preacher, SuperStockTips, Penny Stock Craze, Barchart, Investopedia, Dividend Opportunities, and NBT Equities Research reported recently on PetroTerra Corp. (PTRA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed PetroTerra Corp. is a crude oil and natural gas exploration and development company. It engages in identifying, evaluating, and developing early-stage onshore oil and gas opportunities in North America. The Company was formerly known as Loran Connection Corp. It changed its corporate name to PetroTerra Corp. in January 2012. The Company is headquartered in Colorado Springs, Colorado.

PetroTerra’s present focus is the Sevier and Beaver Oil Prospects. Its Sevier and Beaver Oil Prospects are situated along the Central Utah Thrust Belt (the central Utah portion of the Cordilleran Orogenic Belt). This belt has been of interest in petroleum exploration for more than five decades. This is because of its geological similarities to other successful plays in Utah.

In April 2014, PetroTerra acquired the Sevier and Beaver Oil Prospects. This is a combined parcel of 5,950.54 acres located in west-central Utah. PetroTerra’s business strategy is to concentrate on assets situated in high-potential, proven basins that can reduce the geological risks involved in exploration projects.

PetroTerra acquired a 100 percent working interest (WI) and 80 percent net revenue interest (NRI) in the Sevier and Beaver Oil Project and the three associated leases. Its main play will comprise the Sevier Prospect on the two Sevier County leases. The single Beaver County lease contains a large lead with multiple targets that also requires additional evaluation.

Currently commercially viable plays in this area include Wolverine Gas and Oil’s Covenant and Providence Fields. PetroTerra engaged Thompson Solutions LLC to perform the next step in the technical analysis on the Company's Sevier Oil Prospect.

PetroTerra announced this past February that it completed the initial stages of its technical analysis at the Sevier Oil Prospect. The publicly available gravity and magnetic data reviewed in Phase One and the high-resolution gravity survey acquired through Phase Two have been analyzed and delivered to the Company.

Mr. Kurt Reinecke, PetroTerra Chief Operating Officer, stated, "The gravity and magnetic data we reviewed as part of our initial mapping effort provided sufficient encouragement for us to proceed to Phase Two, which called for a detailed proprietary data collection and interpretation over the Sevier Prospect. The second phase involved acquiring and interpreting a high-resolution gravity survey that overlaps the public data, but at a much greater level of detail."

PetroTerra Corp. (PTRA), closed Tuesday's trading session at $0.249, even for the day, on 9,900 volume with 8 trades. The average volume for the last 60 days is 70,570 and the stock's 52-week low/high is $0.152/$1.89.

SinglePoint, Inc. (SING)

MoneyTV, Equity Observer, MyBestStockAlerts, Stock Commander, and Xtremepicks reported on SinglePoint, Inc. (SING), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

SinglePoint, Inc. is a full-service mobile technology and marketing provider. The Company provides custom business solutions for small to mid-size businesses. Its solutions allow its clients to conduct business transactions, accept donations, and engage in targeted communication by way of mobile devices. SinglePoint is headquartered in Phoenix, Arizona and the Company’s shares trade on the OTC Markets Group’s OTCQB.

SinglePoint’s products connect small to mid-size companies to their target markets through providing inventive mobile technology at reasonable rates. Its solutions make any communication with consumers instantly interactive. This is regardless of what media channel is employed to communicate. SinglePoint permits companies to sell products and services and accept donations beyond the Point of Sale (POS) and outside of events. SinglePoint has global capabilities. The Company can process transactions from anywhere in a host of diverse currencies.

Regarding Fundraising, its solution is Text2Bid. Text2Bid offers an enjoyable, interactive means to increase auction revenues. Text2Bid makes it easy for people to bid in auctions from any text or web-enabled phone. Concerning Payment Solutions, SinglePoint offers Pay by Text™, which allows businesses to accept payments, anytime, anywhere. Pay by Text™ makes every mobile phone a point of sale (POS) device.

SinglePoint also offers Oomy, which enables a business to take control of its delivery service. Oomy enables companies of all kinds to track and manage their fleet vehicles, drivers, as well as deliveries. SinglePoint’s innovative locational tracking technology permits a company to pull up a map and locate all their drivers instantly and view whether they are en-route, taking the proper directions, and get an ETA of their arrival.

In late May, SinglePoint announced that it signed a license distribution agreement with Glympse®, a pioneering location sharing Technology Company, to market dynamic location capabilities to Small- and Medium-sized businesses (SMB) via its Oomy application. Glympse’s technology enables smartphone users to share their location with anyone for a pre-determined period of time.

Today, SinglePoint and Havana Holdings, Inc., a Nevada corporation, finalized agreements for the acquisition of GreenStar Payment Solutions, Inc., including the brand itself and all of the underlying IP in a purchase valued at $1,400,000. The emphasis of Havana's business plan will be developing a low cost E-cigarette brand (vape) targeted specifically to the 30 million strong Hispanic market.

Havana Holdings will issue SinglePoint 57,100,000 shares of common stock and the holder of Havana's outstanding preferred shares will convert these preferred shares into common stock. After the Closing, the estimation is that SinglePoint will own approximately 75 percent of Havana Holdings’ company stock.

Havana Holdings’ intention is to continue SinglePoint's business plan for GreenStar. This plan is to develop new and existing relationships for a product roll out, which will include traditional and smokeless tobacco products. These will run the gamut from electronic cigarettes, vape pens and, contingent on the trade embargo being lifted, Cuban cigars.

GreenStar Payment Solutions is a company formed to create value-added payment solutions in the Cannabis Industry. SinglePoint has redirected the brand to concentrate on the development and distribution of vape pens and e-cigarettes.

SinglePoint, Inc. (SING), closed Tuesday's trading session at $0.0093, down 15.45%, on 1,062,209 volume with 26 trades. The average volume for the last 60 days is 715,557 and the stock's 52-week low/high is $0.003/$0.0245.

The Guitammer Company, Inc. (GTMM)

Stock Legends, Pumps and Dumps, FeedBlitz, and Stock Guru reported previously on The Guitammer Company, Inc. (GTMM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The Guitammer Company, Inc. is a leader in low frequency audio products and broadcast technology. The Company is the creator of the award-winning line of ButtKicker®-brand low frequency audio transducers. These provide an immersive entertainment experience for audiences. The Guitammer Company has its corporate headquarters in Westerville, Ohio. The Company lists on the OTCQB.

The Guitammer Company's patented and patent pending broadcast technologies, "ButtKicker Live!® or "4D Sports powered by ButtKicker", permits the excitement, impact, and also feeling of live sporting events to be broadcast along with the sound and video. It puts the viewer into the action, whether at home or at the event. "4D Sports powered by ButtKicker" technology is available for cable, satellite, fiber optic, IPTV, and over-the-air broadcasts.

ButtKicker-brand low frequency audio transducers let users feel low-frequency sound (bass). They are musically accurate, strong and virtually indestructible. They are used worldwide by leading entertainment and theater companies in movie theaters and attractions. They are also used by renowned musicians; and in home theaters, by consumers for video games, simulators and car audio. Additionally, they are distributed by Pearl Drums for musicians under the trade name, "Pearl's Throne Thumper by ButtKicker".

Last week, The Guitammer Company announced that its promotional partnership with Warner Bros. Pictures for The San Andreas Experience in 4D, was well received by movie fans globally. The action thriller "San Andreas," from New Line Cinema, Village Roadshow Pictures and Warner Bros. Pictures, opened in theaters on May 29, 2015.

The San Andreas Experience in 4D tour features two 91 seat and one 24 seat expanding "mobile cinema" trailers. These are travelling throughout the United States, Europe, and Mexico. Every seat in all three mobile cinemas is outfitted with a ButtKicker® unit. This brings an extraordinary sense of realism to the audience.

Mr. Mark Luden, President of The Guitammer Company, stated, "We couldn't be more thrilled to work closely with the team at Warner Bros. Pictures on The San Andreas Experience in 4D tour. We're very pleased that Warner Bros. Pictures chose ButtKicker products as the best way to add immersion to these very cool mobile cinemas. We continue to see demand by the movie studio and exhibitors for our products as a way to engage and thrill audience worldwide."

The Guitammer Company, Inc. (GTMM), closed Tuesday's trading session at $0.12, up 84.62%, on 38,850 volume with 3 trades. The average volume for the last 60 days is 6,387 and the stock's 52-week low/high is $0.02/$0.16.


The QualityStocks
Company Corner


International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.0496, up 2.06%, on 499,000 volume with 18 trades. The stock’s average daily volume over the past 60 days is 791,574, and its 52-week low/high is $0.045/$0.153.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.

The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.

In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation to Present at International Society for Cellular Therapy Annual Meeting

International Stem Cell Corporation Announces 2015 First Quarter Results

International Stem Cell Corporation Publishes Results Demonstrating Treatment of Parkinson's Disease in Cell Transplantation

Car Monkeys Group (CKMY)

The QualityStocks Daily Newsletter would like to spotlight Car Monkeys Group (CKMY). Today, Car Monkeys Group closed trading at $0.16, up 6.67%, on 3,700 volume with 4 trades. The stock’s average daily volume over the past 60 days is 7,607, and its 52-week low/high is $0.05/$5.00.

Car Monkeys Group (CKMY), via CarMonkeys.com, is one of the largest and fastest growing online cars, vans and SUV parts distributors in the United States. Founded in 2010, the Wyckoff, New Jersey-based company formerly was known as Delaine Corporation and changed its name to Car Monkeys Group in February 2015.

With access to hundreds of thousands of parts, Car Monkeys sells used, high-quality, low-mileage automotive parts to consumers, retailers, truck and car fleet owners and auto repair facilities looking for a wide range of vehicle makes and models. Customers have access to a Part Finder section that helps them easily navigate and quickly locate the right parts they need.

Striving to provide customers a quick, hassle-free and convenient shopping experience, all parts ordered through CarMonkeys.com ship from one of the company’s numerous distributors and auto dismantling centers straight to the customer or their mechanic. Advantages such as a five-year unlimited mileage warranty, zero shipping costs, and a generous return policy further contribute to the increasing popularity of the Car Monkeys brand.

Automotive recycling plays a substantial role in the preservation of natural resources and reduction of demand for landfill space. According to the Automotive Recyclers Association, approximately 95% of vehicles retired from use are processed for recycling, saving an estimated 85 million barrels of oil that would have been used to manufacture new or replacement parts. As a rapidly growing and trusted automotive recycling company, Car Monkeys is positioned as a leading player in the broader $22 billion North American automotive recycling industry. Disclaimer

Car Monkeys Group Company Blog

Car Monkeys Group News:

Car Monkeys Group (CKMY) Announces Engagement of QualityStocks Investor Relations Services

Car Monkeys Group (CKMY) is “One to Watch”

Car Monkeys Group (CKMY) Continues Growth as one of the Country’s Largest Online Automobile Parts Distributors

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.004, even for the day, on 30,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 98,974, and its 52-week low/high is $0.0013/$0.015.

Consorteum Holdings, Inc. (CSRH) has spent the last 3 years developing relationships and licensing agreements to take the center stage in the emerging market of mobile gaming. The company has the capability to deliver rich mobile content to end users who will use their smart phones in ways that could not even have been imagined five years ago.

Specializing in delivery of mobile content, mobile payment solutions and products through a mix of on-deck partnerships, license agreements, and joint venture revenue share arrangements, the company operates as a technology and services aggregator to meet the diverse needs of its client base. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.

ThreeFiftyNine Inc., a wholly owned subsidiary, hired a software development team that had previously designed the world’s first regulatory compliant mobile platform for delivery of gaming content created by a third party. The platform, which has met the rigorous standards of the Nevada Gaming Board, the gold standard in regulatory gaming, represents the first generation software delivery platform for mobile devices. The development team spent the past 5 years and millions of dollars in non-recurring engineering costs to complete the development of the platform. At the heart is the capability to deliver any digital content across any cellular network to any mobile device. This key differentiator makes it possible for Consorteum to approach many different markets that are in the business of providing mobile connectivity and mobile content.

Consorteum’s mobile initiatives will benefit multiple business verticals. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer

Consorteum Holdings, Inc. Company Blog

Consorteum Holdings, Inc. News:

Consorteum Holdings Signs License Agreement With NYG Holdings

Consorteum Holdings Signs Mobile Application Development Contract With Bet Butler Limited

Consorteum Holdings Launches New Mobile Results App for Popular Keno Game

Loans4Less.com, Inc. (LFLS)

The QualityStocks Daily Newsletter would like to spotlight Loans4Less.com, Inc. (LFLS). Today, Loans4Less.com, Inc. closed trading at $0.19, even for the day. The stock’s average daily volume over the past 60 days is 4,268, and its 52-week low/high is $0.015/$0.20.

Loans4Less.com, Inc. (LFLS) is an online mortgage broker which matches qualified individuals seeking mortgage loans with suitable lenders who offer the company a competitive wholesale lending program. Maintaining an A+ TrustLink rating with the Better Business Bureau, the company provides competitive rates, terms, costs, daily updates, extensive market information, and trusted first-class service to the public.

Leveraging its portfolio of 62 different web domains, Loans4Less.com is focused on developing a national consumer platform for conforming residential mortgage programs and implementation of other consumer loan programs via operating providers. The company's expansion strategy includes rapidly growing revenues through strategic and cost-effective advertising, licensing, and/or third party agreements that build national recognition of the Loans4Less® brand.

The management team has accumulated many years of experience in the real estate and financial services sectors. This combination of expertise provides the knowledge and foresight necessary to get the best results for the company and their thousands of loyal clients. The team skillfully navigated through the credit crisis that destroyed much of their competition, putting the company in a stronger position to increase market share.

Loans4Less.com is not exposed to the risks and/or problems that are associated with sub-prime lending. Having never defaulted on an obligation or been involved in any litigation, the company is poised for rapid growth in today's low interest rate environment with its industry leading reputation and well established relationships with respected lenders. Disclaimer

Loans4Less.com, Inc. Company Blog

Loans4Less.com, Inc. News:

LOANS4LESS.COM Enters into an Acquisition Agreement with 321LEND

Loans4Less.com, Inc. Enters into an Investment Banking Agreement with WestPark Capital, Inc. and Seeks Bank Strategic Partner for National Mortgage Broker Origination and Brand Exposure Opportunity

Loans4Less.com Seeks a Merger, Joint Venture Partner and/or Investor for National Loan Origination and Brand Exposure Opportunity

MIT Holding (MITD)

The QualityStocks Daily Newsletter would like to spotlight MIT Holding (MITD). Today, MIT Holding closed trading at $0.04, even for the day. The stock’s average daily volume over the past 60 days is 5,525, and its 52-week low/high is $0.032/$0.29.

MIT Holding (MITD), through its agents, facilitators and contractual obligations, offers professional outpatient medical care with ambulatory infusion therapies, home infusion services, and medical equipment delivery. The company is also pursuing government contacts to obtain approval to import pharmaceutical products into the Americas.

In support of these core services, MIT Holding provides expert legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act; offers travel and transportation services of medically challenged patients for medical needs and personal travel; and through its contracts is approved to, conduct and administer FDA clinical trials.

Collectively, these services contribute to MIT Holding’s strategy to provide custom prescription solutions in a variety of methods and generate multiple revenue streams. Following a successful reorganization initiative in January, 2014, MIT Holding is positioned to achieve 32% minimum net profits and has maintained profitability in its fiscal second and third quarters. This profitability validates the company’s business model and its approach to the evolving Affordable Health Care Act and its impact on the health services industry.

MIT Holding meets and/or exceeds major U.S. health insurance requirements and is therefore able to direct bill and receive payments from carriers on behalf of the patient its agents and its facilitators. This ability marks an important step in the company’s goal of developing the first-of-its-kind seamless transition for patient needs from hospital discharge to complete home recovery. This and other corporate initiatives are spearheaded by a management team committed to building shareholder value, revenues and corporate expansion while providing viable solutions to the perpetual changes in the health care sector. Disclaimer

MIT Holding Company Blog

MIT Holding News:

MIT Holding Achieves Positive Net Income From Operations in 2014

MIT Holding (MITD) Launches New Website with Investor Relations Suite

MIT Holding, Inc. Names Tommy J. Duncan as President


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters







The Street

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251